CINRYZE

This brand name is authorized in Austria, Brazil, Canada, Estonia, Spain, Finland, France, Croatia, Ireland, Lithuania, Netherlands, Poland, Romania, Turkey, United Kingdom, United States

Active ingredients

The drug CINRYZE contains one active pharmaceutical ingredient (API):

1 C1-inhibitor UNII 6KIC4BB60G - HUMAN C1-ESTERASE INHIBITOR

C1 inhibitor is a single chain glycoprotein found in plasma and a member of the serine protease inhibitor, or serpin, superfamily of proteins. C1 inhibitor inhibits the complement system by binding C1r and C1s and is the most important inhibitor of contact activation, regulating the contact system and the intrinsic coagulation pathway by binding to and inactivating kallikrein and factor XIIa. Read about C1-inhibitor

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
CINRYZE Powder and solvent for solution for injection	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B06AC01	C1-inhibitor, plasma derived	B Blood and blood forming organs → B06 Other hematological agents → B06A Other hematological agents → B06AC Drugs used in hereditary angioedema
Discover more medicines within B06AC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 540220100007307
Country: CA	Health Products and Food Branch	Identifier(s): 02395371
Country: EE	Ravimiamet	Identifier(s): 1533035
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 11688001
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 136121
Country: FR	Base de données publique des médicaments	Identifier(s): 69014721
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 200237
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1061561
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 44512
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100309042
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68875001
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699943790103
Country: US	FDA, National Drug Code	Identifier(s): 42227-081